Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection? - PubMed (original) (raw)
Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?
A L Martinelli et al. Acta Haematol. 2000.
Abstract
It has been proposed that iron overload may adversely affect liver disease outcome. The recent identification of 2 mutations in the HFE gene related to hereditary haemochromatosis (Cys282Tyr and His63Asp) provided an opportunity to test whether they are associated with hepatic iron accumulation and the activity and severity of liver disease in hepatitis C virus (HCV) infection. We investigated the prevalence of HFE mutations in 135 male patients with chronic HCV hepatitis, and correlated genotype distribution with different parameters of iron status and the activity and severity of liver disease. Of these 135 patients, 6 (4.4%) carried Cys282Tyr and 32 (23.7%) carried His63Asp, frequencies which were similar to those observed in healthy controls. Serum iron levels and transferrin saturation (but not ferritin levels or liver iron content) were significantly higher in carriers than in non-carriers of HFE mutations. No difference was observed in serum ALT, AST and GGT levels between carriers and non-carriers. Finally, scores for necroinflammatory activity and fibrosis in the liver were significantly higher in HFE carriers than in non-carriers. Patients with chronic HCV infection carrying HFE mutations tend to present more evident body iron accumulation and a higher degree of necroinflammatory activity and fibrosis in the liver. HFE gene mutations might be an additional factor to be considered among those implicated in the determination of a worse prognosis of the liver disease in chronic HCV infection.
Copyright 2000 S. Karger AG, Basel
Similar articles
- The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C.
Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, Fox R, McCruden EA, MacSween RN, Mills PR. Thorburn D, et al. Gut. 2002 Feb;50(2):248-52. doi: 10.1136/gut.50.2.248. Gut. 2002. PMID: 11788568 Free PMC article. - HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
Remacha AF, Carrasco M, Sardá MP, Barceló MJ, Baiget M. Remacha AF, et al. Haematologica. 1999 Mar;84(3):284-5. Haematologica. 1999. PMID: 10189401 No abstract available. - Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Tung BY, et al. Gastroenterology. 2003 Feb;124(2):318-26. doi: 10.1053/gast.2003.50046. Gastroenterology. 2003. PMID: 12557137 - Role of hemochromatosis genes in chronic hepatitis C.
Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R, Baldassarre R. Gattoni A, et al. Clin Ter. 2006 Jan-Feb;157(1):61-8. Clin Ter. 2006. PMID: 16669553 Review. - [From gene to disease; HFE-mutations in primary haemochromatosis].
Swinkels DW, Jacobs EM. Swinkels DW, et al. Ned Tijdschr Geneeskd. 2003 Apr 5;147(14):652-6. Ned Tijdschr Geneeskd. 2003. PMID: 12712648 Review. Dutch.
Cited by
- Manipulation of iron to determine survival: competition between host and pathogen.
Laham N, Ehrlich R. Laham N, et al. Immunol Res. 2004;30(1):15-28. doi: 10.1385/IR:30:1:015. Immunol Res. 2004. PMID: 15258308 Review. - Iron overload disorders.
Hsu CC, Senussi NH, Fertrin KY, Kowdley KV. Hsu CC, et al. Hepatol Commun. 2022 Aug;6(8):1842-1854. doi: 10.1002/hep4.2012. Epub 2022 Jun 14. Hepatol Commun. 2022. PMID: 35699322 Free PMC article. Review. - Comprehensive analysis of HFE gene in hereditary hemochromatosis and in diseases associated with acquired iron overload.
de Campos WN, Massaro JD, Cançado ELR, Wiezel CEV, Simões AL, Teixeira AC, de Souza FF, Mendes-Junior CT, Martinelli ALC, Donadi EA. de Campos WN, et al. World J Hepatol. 2019 Feb 27;11(2):186-198. doi: 10.4254/wjh.v11.i2.186. World J Hepatol. 2019. PMID: 30820268 Free PMC article. - Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.
Jonsson JR, Purdie DM, Clouston AD, Powell EE. Jonsson JR, et al. Mol Diagn Ther. 2008;12(4):209-18. doi: 10.1007/BF03256286. Mol Diagn Ther. 2008. PMID: 18652517 Review. - Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study.
Dawood RM, Abd El Meguid M, Elrobe W, Salum GM, Zayed N, Mousa S, Medhat E. Dawood RM, et al. Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2837-2845. doi: 10.31557/APJCP.2021.22.9.2837. Asian Pac J Cancer Prev. 2021. PMID: 34582652 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous